Decreased insulin resistance in diabetic patients by influencing Sirtuin1 and Fetuin-A following supplementation with ellagic acid: a randomized controlled trial.

Mahnaz GhadimiFarshad ForoughiSima HashemipourMohammadreza Rashidi NooshabadiMohammad Hossein AhmadiMojtaba Ghadimi YariMaria KavianpourHossein Khadem Haghighian

Published in: Diabetology & metabolic syndrome (2021)

EA with antioxidant properties plays an essential role in reducing the macrovascular and microvascular complications of diabetes by reducing inflammation and insulin resistance. Trial registration The protocol of this clinical trial is registered with the Iranian Registry of Clinical Trials ( http://www.IRCT.IR , identifier: IRCT20141025019669N13).

Keyphrases

clinical trial
phase ii
insulin resistance
oxidative stress
phase iii
type diabetes
study protocol
open label
cardiovascular disease
randomized controlled trial
glycemic control
double blind
adipose tissue
risk factors
metabolic syndrome
high fat diet
anti inflammatory
polycystic ovary syndrome
placebo controlled